This brand name is authorized in Austria, Estonia, Spain, France, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland, United Kingdom, United States
The drug NULOJIX contains one active pharmaceutical ingredient (API):
1
Belatacept
UNII E3B2GI648A - BELATACEPT
|
Belatacept, a modified form of CTLA4-Ig, binds CD80 and CD86 more avidly than the parent CTLA4-Ig molecule from which it is derived. This increased avidity provides a level of immunosuppression that is necessary for preventing immune-mediated allograft failure and dysfunction. Belatacept blocks CD28 mediated co-stimulation of T cells inhibiting their activation. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
NULOJIX Powder for concentrate for solution for infusion | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
L04AA28 | L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AA Selective immunosuppressants | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: EE | Ravimiamet | Identifier(s): 1533215, 1533226 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 11694002 |
Country: FR | Base de données publique des médicaments | Identifier(s): 69597619 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 194635, 194636 |
Country: IT | Agenzia del Farmaco | Identifier(s): 041282017, 041282029 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1061230, 1061231 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 101044 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100247950 |
Country: US | FDA, National Drug Code | Identifier(s): 0003-0371 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.